Antitumor necrosis treatment in primary sclerosing cholangitis associated inflammatory bowel disease after liver transplantation

被引：11

作者：

Pavlidis, Polychronis ^{[1
]}

Potts, Jonathan ^{[2
]}

Barnabas, Ashley ^{[2
]}

Heaton, Nigel ^{[2
]}

Bjarnason, Ingvar ^{[1
]}

Heneghan, Michael ^{[2
]}

Hayee, Bu'Hussain ^{[1
]}

机构：

[1] Kings Coll Hosp London, Dept Gastroenterol, London SE5 9RS, England

[2] Kings Coll Hosp London, Inst Liver Studies, London SE5 8RX, England

来源：

LIVER TRANSPLANTATION | 2015年 / 21卷 / 11期

关键词：

THERAPY;

D O I：

10.1002/lt.24212

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1455 / 1456

页数：2

共 5 条

[1] Letter: infliximab therapy in inflammatory bowel disease patients after liver transplantation [J].

Indriolo, A. ;

Fagiuoli, S. ;

Pasulo, L. ;

Fiorino, G. ;

Danese, S. ;

Ravelli, P. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (08) :840-842

[2] The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis [J].

Joshi, Deepak ;

Bjarnason, Ingvar ;

Belgaumkar, Ajay ;

O'Grady, John ;

Suddle, Abid ;

Heneghan, Michael A. ;

Aluvihare, Varuna ;

Rela, Mohammed ;

Heaton, Nigel ;

Agarwal, Kosh .

LIVER INTERNATIONAL, 2013, 33 (01) :53-61

[3] Anti-tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipients [J].

Mohabbat, A. B. ;

Sandborn, W. J. ;

Loftus, E. V., Jr. ;

Wiesner, R. H. ;

Bruining, D. H. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (06) :569-574

[4] Cholestyramine Treats Primary Sclerosing Cholangitis-Associated Inflammatory Bowel Disease [J].

Pavlidis, Polychronis ;

Heneghan, Michael ;

Hayee, Bu'Hussain .

JOURNAL OF CROHNS & COLITIS, 2015, 9 (02) :210-210

[5] The safety and efficacy of antitumour necrosis factor-alpha therapy for inflammatory bowel disease in patients post liver transplantation: a case series [J].

Sandhu, A. ;

Alameel, T. ;

Dale, C. H. ;

Levstik, M. ;

Chande, N. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (02) :159-165

← 1 →